Arca
Skip to content
Tools
Tools

Geographic atrophy

Drug research and approvals for geographic atrophy: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 45 studies of geographic atrophy are recruiting on ClinicalTrials.gov, and Health Canada has authorized 2 drug trials for it since 2013.

  • Recruiting worldwide: 45
  • Trials authorized in Canada: 2
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 45 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 5

Phase 2 12 of 15

Phase 1 or earlier 2

How its trials ended

144 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 45 whose ending is known, 20% met their primary endpoint, 13% missed it and 67% stopped early.

  • Completed, result not reported4833%
  • Ongoing4229%
  • Stopped: other or unclear1510%
  • Met its primary endpoint96%
  • Stopped: lack of efficacy96%
  • Status unknown96%
  • Missed its primary endpoint64%
  • Stopped: sponsor or business decision53%
  • Stopped: funding11%

Trials authorized in Canada

Newest first; search them all in Canada trials
Feb 6, 2026A randomized, double masked, placebo-controlled, multicenter, dose-range finding study to assess the efficacy and safety of FWY003 in participants with…FWY003Novartis PharmaceuticalsOngoing
May 16, 2025A phase 2 multicenter, randomized, double-masked, sham controlled, reference-arm study to evaluate efficacy and safety of ONL1204 in patients with geographic…ONL1204ONL TherapeuticsOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.